Medication Safety in Prisons

The included prison medication safety evidence is geographically concentrated in the USA and UK, limiting global generalisability. Prisons are high-risk medication environments because incarcerated populations have high disease burdens and prison healthcare faces operational constraints. Security protocols can delay or restrict treatment even though prisoners are entitled to community-equivalent healthcare. The review mapped evidence on drug-related problems in prison healthcare, including medication errors, adverse reactions and events, inappropriate prescribing, and non-adherence.